MSB 2.94% $1.14 mesoblast limited

banter and General Discussion, page-10297

  1. 15,470 Posts.
    lightbulb Created with Sketch. 5559
    Yes …. Finally ….. now where is the CLBP partnership - we don’t have enough funds to see this through as at today’s cash position although we are due a payment from Grunenthal when the EU part of the trial starts ?


    GLTAH

    https://www.clinicaltrials.gov/study/NCT06325566?intr=Rexlemestrocel-L + HA mixture&rank=1


    RECRUITING
    Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain (HyaluronicAcid)

    ClinicalTrials.gov ID NCT06325566

    Sponsor Mesoblast, Ltd.

    Information provided by Mesoblast, Ltd. (Responsible Party)

    Last Update Posted 2024-07-18
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.14
Change
0.033(2.94%)
Mkt cap ! $1.295B
Open High Low Value Volume
$1.08 $1.14 $1.08 $3.060M 2.760M

Buyers (Bids)

No. Vol. Price($)
36 76648 $1.14
 

Sellers (Offers)

Price($) Vol. No.
$1.14 103568 15
View Market Depth
Last trade - 15.02pm 19/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.